# Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia

> **NCT00158223** · PHASE4 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 76 (actual)

## Conditions studied

- Schizophrenia
- Psychotic Disorders

## Interventions

- **DRUG:** Pimozide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00158223
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2015-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00158223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00158223, "Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00158223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*